Digital Twin Study Predicts Higher Thrombotic Recurrence with DOACs vs VKAs in APS Patients
APS Support UK has shared a post on X:
“A digital twin model (n=89) assessed thrombotic recurrence in APS treated with DOACs vs VKAs.
DOACs: 24.2% recurrence
VKAs: 19.9%
Risk higher with DOACs in triple-positive and arterial cases.
Comparable in non-triple-positive and venous.”
Title: A Digital Twin Strategy to Predict Thrombotic Recurrence in Antiphospholipid Syndrome Patients Treated with Direct Oral Anticoagulants vs. Vitamin K Antagonists Using Data from Real-World Populations
Authors: Miguel Ángel Casado-Suela, Juan Torres-Macho, Aida Izquierdo-Martínez, Cristina Lucía Ancos-Aracil, Luis Ferreira-Burguillos, Elena Madroñal-Cerezo, Tamar Talaván-Zañón, Adela Castañeda-Mata, Luis Escobar-Curbelo, Ana Martínez de la Casa-Muñoz, Eva Ruiz-Navío, Ana Bustamante-Fermosel, Anabel Franco-Moreno
Read the full paper here.
Discover more on Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026